G3BP1/2-Targeting PROTAC Disrupts Stress Granules Dependent ATF4 Migracytosis as Cancer Therapy

Ting Dong1,2, Fabao Zhao3, Mengmeng Wang2

  • 1State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 2A Nanwei Road, Xicheng District, Beijing 100050, China.

Insights

New compounds targeting stress granules (SGs) inhibit cancer growth by blocking the transfer of the survival factor ATF4 from fibroblasts to tumor cells. This discovery offers novel therapeutic strategies for cancer treatment.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • Stress granules (SGs) are dynamic cytoplasmic structures formed under cellular stress.
  • Activating transcription factor 4 (ATF4) is preferentially translated within SGs to promote cell survival.
  • The role of SGs and ATF4 in cancer progression within the tumor microenvironment is not fully understood.

Purpose of the Study:

  • To investigate the role of stress granules in cancer cell proliferation.
  • To develop small molecules targeting SG dynamics for cancer therapy.
  • To elucidate the mechanism of ATF4 delivery via SGs in fibroblast-mediated tumor growth.

Main Methods:

  • Design and synthesis of small molecules (#129 and PT-129) targeting G3BP1/2.
  • Inhibition of stress granule formation and disassembly of pre-existing SGs.
  • In vitro and in vivo assays to assess the effect of PT-129 on cancer cell growth and tumor progression.
  • Investigation of ATF4 delivery mechanisms via migracytosis.

Main Results:

  • Compounds #129 and PT-129 effectively inhibit SG formation and disassemble existing SGs.
  • Pharmacological inhibition of SGs by PT-129 suppressed fibroblast-mediated cancer cell growth in vitro.
  • PT-129 treatment reduced tumor growth in vivo.
  • Stress granules facilitate ATF4 delivery from fibroblasts to tumor cells through migracytosis, which is disrupted by PT-129.

Conclusions:

  • Stress granules play a critical role in promoting cancer cell proliferation by mediating ATF4 delivery.
  • Targeting G3BP1/2 and modulating SG dynamics with compounds like PT-129 presents a promising therapeutic strategy for cancer.
  • These findings provide new molecular insights into SG function and their therapeutic potential in oncology.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K